Pharmaion
+1 8448850006     sales@pharmaion.com
Report Description

United States Osteoporosis Drugs Market Opportunities, 2011 - 2021

United States Osteoporosis Drugs Market Opportunities, 2011 - 2021
  • Publish Date:March, 2016
  • Format : PDF
  • Pages : 101

As per the International Osteoporosis Foundation, osteoporosis is a disease in which the density and quality of bones reduce. Losing bone density is a normal part of aging process, however, in some cases it leads to the development of osteoporosis. As bones becomes more porous and fragile, the risk of fracture increases. Most common fractures associated with osteoporosis occurs at hip, wrist and vertebrae.

High prevalence of osteoporosis, growing ageing population, and increasing life expectancy are anticipated to aid the demand for osteoporosis drugs in the United States over the next five years. Moreover, an increasing number of international players foraying the market coupled with growing awareness regarding osteoporotic care among consumers is expected to have a positive impact on the osteoporosis drugs market in the United States in the coming years.

“United States Osteoporosis Drugs Market Opportunities, 2011 - 2021” report studies the market size and share of various segments and sub-segments of the osteoporosis drugs market in the United States during the period 2011 - 2021. In the study, the market has been categorized into six broader segments that include Bisphosphonates, Calcitonins, Selective Estrogen Receptor Modulators (SERMs), Parathyroid Hormone (PTH), Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL) & Others.

The market dynamics section of the report elaborates the factors that are driving the market as well as the challenges inhibiting growth. The research study also includes insights of the key market trends, a detailed analysis of the changing competitive landscape, and revenue forecasts for each segment and sub-segment.

All this information is provided to assist the established market players and new entrants in taking their strategic decisions, thereby aiding them in strengthening their market position in a highly competitive osteoporosis drugs market in the United States.

“United States Osteoporosis Drugs Market Opportunities, 2011 - 2021” report elaborates the following aspects of osteoporosis drugs market in the United States:

ü  United States Osteoporosis Drugs Market Size, Share & Forecast

ü  Segmental Analysis – By Type (Bisphosphonates, Calcitonins, Selective Estrogen Receptor Modulators (SERMs), Parathyroid Hormone (PTH), Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL) & Others), By Sales Channel (Retail & Non Retail), By Region, By Company

ü  Policy & Regulatory Landscape

ü  Changing Market Trends & Emerging Opportunities

ü  Competitive Landscape & Strategic Recommendations

Why You Should Buy This Report?

ü  To identify the on-going trends and anticipated growth in the next five years

ü  To gain competitive knowledge of leading market players

ü  To avail 10% customization in the report without any extra charges and get the research data or trends added in the report as per the buyer’s specific needs   

Key Questions This Study Will Answer

ü  What would be the segmental and regional growth trends in the United States osteoporosis drugs market in the coming years?

ü  What are the most important growth drivers and opportunities in the market?

ü  Which drug is preferred the most?

ü  What strategies should market competitors employ to gain share in mature segments of the United States osteoporosis drugs market?

ü  What are the competitor profiles in this market and how do they compete for market share?

Report Methodology

The information contained in this report is based upon both primary and secondary sources. Primary research included interviews with osteoporosis drugs industry experts. Secondary research included an exhaustive search of relevant publications like company annual reports, financial reports and other proprietary databases.

Please Select Format

Single User License

$2500

Single User License Print

$3000

Enterprise License

$5000

For Queries Please Contact us

sales@pharmaion.com

+1 646 862 0089

10% Customization